Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 1;60(1):7-16.
doi: 10.1093/jrr/rry076.

Purified PEGylated human glucagon-like peptide-2 reduces the severity of irradiation-induced acute radiation enteritis in rats

Tian Zhang  1 , Lei Shi  1 , Yuan Xu  1 , Yang Li  1 , Shicao Li  1 , Bo Guan  1 , Zhihua Qi  1 , Ye Zhang  2 , Linna Liu  1
Affiliations

Purified PEGylated human glucagon-like peptide-2 reduces the severity of irradiation-induced acute radiation enteritis in rats

Tian Zhang et al. J Radiat Res. .

Abstract

Radiation-induced acute intestinal injury after abdominal and pelvic irradiation is a common and serious problem in the clinical setting. Glucagon-like peptide-2 (GLP-2), a 33-amino acid peptide, exerts diverse effects related to the regulation of gastrointestinal growth and function. However, GLP-2 is relatively unstable in vivo. The aim of the present study was to improve GLP-2 stability in vivo and to evaluate its therapeutic effect on acute radiation enteritis. We generated long-lasting intestinal protection peptides by conjugating human GLP-2 (hGLP-2) peptides to polyethyleneglycol (PEG) to produce mPEGylation hGLP-2 (Mono-PEG-hGLP-2) through an enzymatic site-specific transglutamination reaction. Mono-PEG-hGLP-2 synthesized under optimal reaction conditions and separated by one-step ion-exchange chromatography was found to be resistant to degradation in vitro. Pretreatment with Mono-PEG-hGLP-2 reduced the severity of radiation-induced intestinal injury, oxidative stress, and the expression of NF-κB in rats with irradiation-induced acute radiation enteritis. The enhanced biological potency of Mono-PEG-hGLP-2 highlights its potential as a therapeutic agent for intestinal diseases.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
(a) Mono-PEG-hGLP-2 yield in different molar ratios of mPEG-SPA to pGLP-2, *P < 0.05 vs the molar ratio of mPEG-SPA to pGLP-2, 2:1. (b) The conversion ratio of Mono-PEG-hGLP-2 in different concentrations of GLP-2, *P < 0.05 vs the concentration of GLP-2 in 1 mg/ml. (c) Influence of reaction temperature and reaction time on the yield of Mono-PEG-hGLP-2. (d) Proteolytic stability of Mono-PEG-hGLP-2 and GLP-2.
Fig. 2.
Fig. 2.
(a) Reverse-phase high-performance liquid chromatography profiles of GLP-2, reaction mixture, and sediment of reaction; (b) high-performance gel filtration liquid chromatography of purified Mono-PEG-GLP-2 by reverse-phase high-performance liquid chromatography. The purity of Mono-PEG-GLP-2 was 97% and the yield was 95%.
Fig. 3.
Fig. 3.
Histological and morphometric changes in small intestinal villi of the rats. MPG2-L: pretreated with 3 μg of Mono-PEG-hGLP-2. MPG2-M: pretreated with 10 μg of Mono-PEG-hGLP-2. MPG2-H: pretreated with 30 μg of Mono-PEG-hGLP-2.
Fig. 4.
Fig. 4.
Immunohistochemical (a) and Western blot analysis (b) of NF-κB in intestines. MPG2-L: pretreated with 3 μg of Mono-PEG-hGLP-2; MPG2-M: pretreated with 10 μg of Mono-PEG-hGLP-2; MPG2-H: pretreated with 30 μg of Mono-PEG-hGLP-2, *P < 0.05, **P < 0.01 vs model.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Shadad A-K, Sullivan F-J, Martin J-D et al. . Gastrointestinal radiation injury: Symptoms, risk factors and mechanisms. World J Gastroenterol 2013;19:185–98. - PMC - PubMed
    1. Di Fiore F, Van Cutsem E. Acute and long-term gastrointestinal consequences of chemotherapy. Best Pract Res Clin Gastroenterol 2009;23:113–24. - PubMed
    1. Andrade R-S, Voynov G, Lalonde R et al. . Acute gastrointestinal and genitourinary toxicity in women with gynecologic malignancies treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:S558–9.
    1. Shadad A-K, Sullivan F-J, Martin J-D et al. . Gastrointestinal radiation injury: prevention and treatment. World J Gastroenterol 2013;19:199–208. - PMC - PubMed
    1. Demirer S, Aydintug S, Aslim B et al. . Effects of probiotics on radiation-induced intestinal injury in rats. Nutrition 2006;22:179–86. - PubMed

MeSH terms

LinkOut - more resources